
Brian K. Young
Examiner (ID: 3400, Phone: (571)272-1816 , Office: P/2845 )
| Most Active Art Unit | 2819 |
| Art Unit(s) | 2845, 2107, 2104, 2819 |
| Total Applications | 2839 |
| Issued Applications | 2669 |
| Pending Applications | 75 |
| Abandoned Applications | 102 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7634875
[patent_doc_number] => 06656743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-02
[patent_title] => 'Human choline acetyltransferase'
[patent_app_type] => B2
[patent_app_number] => 10/177158
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13596
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177158 | Human choline acetyltransferase | Jun 23, 2002 | Issued |
Array
(
[id] => 990669
[patent_doc_number] => 06919195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Glutaminase, glutaminase gene, novel recombinant DNA, and process for manufacturing glutaminase'
[patent_app_type] => utility
[patent_app_number] => 10/175002
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3931
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175002 | Glutaminase, glutaminase gene, novel recombinant DNA, and process for manufacturing glutaminase | Jun 19, 2002 | Issued |
Array
(
[id] => 1192819
[patent_doc_number] => 06730505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-04
[patent_title] => 'Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 10/162639
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21615
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10162639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/162639 | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | Jun 5, 2002 | Issued |
Array
(
[id] => 6847052
[patent_doc_number] => 20030166219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/153919
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 20824
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153919
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153919 | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | May 23, 2002 | Issued |
Array
(
[id] => 6847051
[patent_doc_number] => 20030166218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/153917
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20553
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153917 | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | May 23, 2002 | Issued |
Array
(
[id] => 6526741
[patent_doc_number] => 20020192694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Novel human hydroxylases and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/154674
[patent_app_country] => US
[patent_app_date] => 2002-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9725
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10154674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/154674 | Human hydroxylases and polynucleotides encoding the same | May 22, 2002 | Issued |
| 10/150028 | METHOD FOR MODIFYING THE SPECIFICITY OF A RESTRICTION- MODIFICATION SYSTEM | May 16, 2002 | Abandoned |
Array
(
[id] => 1123124
[patent_doc_number] => 06794172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-21
[patent_title] => 'Method for cloning and expression of PpuMI restriction endonuclease and PpuMI methylase in E. coli'
[patent_app_type] => B2
[patent_app_number] => 10/150048
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5921
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150048
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150048 | Method for cloning and expression of PpuMI restriction endonuclease and PpuMI methylase in E. coli | May 16, 2002 | Issued |
Array
(
[id] => 6634555
[patent_doc_number] => 20030211561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Human oxalyl-CoA decarboxylase'
[patent_app_type] => new
[patent_app_number] => 10/138697
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8351
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211561.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138697
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138697 | Human oxalyl-CoA decarboxylase | May 5, 2002 | Abandoned |
Array
(
[id] => 1223513
[patent_doc_number] => 06699683
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Active site of human gamma glutamy hydrolase'
[patent_app_type] => B1
[patent_app_number] => 10/135755
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13437
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10135755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/135755 | Active site of human gamma glutamy hydrolase | Apr 29, 2002 | Issued |
Array
(
[id] => 5859098
[patent_doc_number] => 20020123122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Human DNase'
[patent_app_type] => new
[patent_app_number] => 10/133065
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7539
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133065 | Human DNase | Apr 25, 2002 | Abandoned |
Array
(
[id] => 1027837
[patent_doc_number] => 06881565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-19
[patent_title] => 'Protein having glutaminase activity and gene encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/123116
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6317
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123116 | Protein having glutaminase activity and gene encoding the same | Apr 16, 2002 | Issued |
Array
(
[id] => 1119450
[patent_doc_number] => 06797499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-28
[patent_title] => 'Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 10/118037
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 24630
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797499.pdf
[firstpage_image] =>[orig_patent_app_number] => 10118037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/118037 | Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof | Apr 8, 2002 | Issued |
Array
(
[id] => 1115315
[patent_doc_number] => 06800465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-05
[patent_title] => 'D-hydantoinase from Ochrobactrum anthropi '
[patent_app_type] => B2
[patent_app_number] => 10/114810
[patent_app_country] => US
[patent_app_date] => 2002-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11079
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114810 | D-hydantoinase from Ochrobactrum anthropi | Apr 2, 2002 | Issued |
Array
(
[id] => 1056580
[patent_doc_number] => 06855804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-15
[patent_title] => 'Covalently reactive transition state analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/114716
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 21989
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114716 | Covalently reactive transition state analogs and methods of use thereof | Mar 31, 2002 | Issued |
Array
(
[id] => 1009282
[patent_doc_number] => 06900044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => '68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/107695
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 38442
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107695 | 68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor | Mar 26, 2002 | Issued |
Array
(
[id] => 6730173
[patent_doc_number] => 20030186363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli'
[patent_app_type] => new
[patent_app_number] => 10/106275
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5971
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106275
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106275 | Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli | Mar 25, 2002 | Issued |
Array
(
[id] => 6740126
[patent_doc_number] => 20030157495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/098155
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27197
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157495.pdf
[firstpage_image] =>[orig_patent_app_number] => 10098155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/098155 | Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof | Mar 13, 2002 | Abandoned |
Array
(
[id] => 999486
[patent_doc_number] => 06911335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-28
[patent_title] => '57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/098108
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 40633
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/911/06911335.pdf
[firstpage_image] =>[orig_patent_app_number] => 10098108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/098108 | 57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor | Mar 12, 2002 | Issued |
Array
(
[id] => 5921824
[patent_doc_number] => 20020115179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/094989
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 19778
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094989 | Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof | Mar 11, 2002 | Issued |